Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CEFTIBUTEN vs CEFUROXIME: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CEFTIBUTEN vs CEFUROXIME: Safety Overview

Metric CEFTIBUTEN CEFUROXIME
Total FAERS Reports 150 5,209
Deaths Reported 1 439
Death Rate 0.7% 8.4%
Hospitalizations 26 2,274
Average Patient Age 37.1 yrs 56.6 yrs
% Female Patients 58.9% 45.1%
FDA Approval Date Dec 20, 1995 Apr 16, 1998
Manufacturer N/A Sagent Pharmaceuticals
Route N/A INTRAMUSCULAR
Marketing Status Discontinued Discontinued